Skip to main content

Firmagon FDA Approval History

FDA Approved: Yes (First approved December 24, 2008)
Brand name: Firmagon
Generic name: degarelix
Dosage form: for Injection
Company: Ferring Pharmaceuticals, USA
Treatment for: Prostate Cancer

Firmagon (degarelix) is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for patients with advanced prostate cancer.

Development timeline for Firmagon

Dec 29, 2008Approval FDA Approves Ferring Pharmaceuticals' Degarelix for Treatment of Advanced Prostate Cancer

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.